Factors determining penetrance in familial atypical haemolytic uraemic syndrome

被引:25
作者
Sansbury, Francis H. [1 ,2 ,3 ]
Cordell, Heather J. [4 ]
Bingham, Coralie [2 ,5 ]
Bromilow, Gilly [1 ]
Nicholls, Anthony [5 ]
Powell, Roy [6 ]
Shields, Bev [2 ]
Smyth, Lucy [5 ]
Warwicker, Paul [7 ]
Strain, Lisa [8 ]
Wilson, Valerie [8 ]
Goodship, Judith A. [4 ]
Goodship, Timothy H. J. [4 ]
Turnpenny, Peter D. [1 ,2 ]
机构
[1] Royal Devon & Exeter Hosp Heavitree, Royal Devon & Exeter NHS Fdn Trust, Peninsula Clin Genet Serv, Exeter, Devon, England
[2] Univ Exeter, Sch Med, Exeter, Devon, England
[3] St Michaels Hosp, Univ Hosp Bristol NHS Fdn Trust, Bristol Clin Genet Serv, Bristol, Avon, England
[4] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England
[5] Royal Devon & Exeter Hosp Wonford, Royal Devon & Exeter NHS Fdn Trust, Dept Renal Med, Exeter, Devon, England
[6] Royal Devon & Exeter Hosp Wonford, Royal Devon & Exeter NHS Fdn Trust, Res Design Serv South West, Exeter, Devon, England
[7] East & North Hertfordshire NHS Trust, Lister Renal Units, Stevenage, Herts, England
[8] Newcastle Upon Tyne Hosp NHS Fdn Trust, Northern Mol Genet Serv, Newcastle Upon Tyne, Tyne & Wear, England
基金
英国医学研究理事会;
关键词
COMPLEMENT FACTOR-H; MULTILOCUS LINKAGE ANALYSIS; MEMBRANE COFACTOR PROTEIN; GENE-MUTATIONS; DISEASE; RECOGNITION; CFH; SUSCEPTIBILITY; PREDISPOSE; CANCER;
D O I
10.1136/jmedgenet-2014-102498
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Inherited abnormalities of complement are found in similar to 60% of patients with atypical haemolytic uraemic syndrome (aHUS). Such abnormalities are not fully penetrant. In this study, we have estimated the penetrance of the disease in three families with a CFH mutation (c.3643C>G; p. Arg1215Gly) in whom a common lineage is probable. 25 individuals have been affected with aHUS with three peaks of incidence-early childhood (n=6), early adulthood (n= 11) and late adulthood (n= 8). Eighteen individuals who have not developed aHUS carry the mutation. Methods We estimated penetrance at the ages of 4, 27, 60 and 70 years as both a binary and a survival trait using MLINK and Mendel. We genotyped susceptibility factors in CFH, CD46 and CFHR1 in affected and unaffected carriers. Results and Conclusions We found that the estimates of penetrance at the age of 4 years ranged from <0.01 to 0.10, at the age of 27 years from 0.16 to 0.29, at the age of 60 years from 0.39 to 0.51 and at the age of 70 years from 0.44 to 0.64. We found that the CFH haplotype on the allele not carrying the CFH mutation had a significant effect on disease penetrance. In this family, we did not find that the CD46 haplotypes had a significant effect on penetrance.
引用
收藏
页码:756 / 764
页数:9
相关论文
共 41 条
  • [1] Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome
    Abarrategui-Garrido, Cynthia
    Martinez-Barricarte, Ruben
    Lopez-Trascasa, Margarita
    Rodriguez de Cordoba, Santiago
    Sanchez-Corral, Pilar
    [J]. BLOOD, 2009, 114 (19) : 4261 - 4271
  • [2] Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degeneration
    Ansari, Morad
    Mckeigue, Paul M.
    Skerka, Christine
    Hayward, Caroline
    Rudan, Igor
    Vitart, Veronique
    Polasek, Ozren
    Armbrecht, Ana-Maria
    Yates, John R. W.
    Vatavuk, Zoran
    Bencic, Goran
    Kolcic, Ivana
    Oostra, Ben A.
    Van Duijn, Cornelia M.
    Campbell, Susan
    Stanton, Chloe M.
    Huffman, Jennifer
    Shu, Xinhua
    Khan, Jane C.
    Shahid, Humma
    Harding, Simon P.
    Bishop, Paul N.
    Deary, Ian J.
    Moore, Anthony T.
    Dhillon, Baljean
    Rudan, Pavao
    Zipfel, Peter F.
    Sim, Robert B.
    Hastie, Nicholas D.
    Campbell, Harry
    Wright, Alan F.
    [J]. HUMAN MOLECULAR GENETICS, 2013, 22 (23) : 4857 - 4869
  • [3] Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations
    Barrow, E.
    Alduaij, W.
    Robinson, L.
    Shenton, A.
    Clancy, T.
    Lalloo, F.
    Hill, J.
    Evans, D. G.
    [J]. CLINICAL GENETICS, 2008, 74 (03) : 233 - 242
  • [4] Combined Complement Gene Mutations in Atypical Hemolytic Uremic Syndrome Influence Clinical Phenotype
    Bresin, Elena
    Rurali, Erica
    Caprioli, Jessica
    Sanchez-Corral, Pilar
    Fremeaux-Bacchi, Veronique
    Rodriguez de Cordoba, Santiago
    Pinto, Sheila
    Goodship, Timothy H. J.
    Alberti, Marta
    Ribes, David
    Valoti, Elisabetta
    Remuzzi, Giuseppe
    Noris, Marina
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 24 (03): : 475 - 486
  • [5] Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease
    Caprioli, J
    Castelletti, F
    Bucchioni, S
    Bettinaglio, P
    Bresin, E
    Pianetti, G
    Gamba, S
    Brioschi, S
    Daina, E
    Remuzzi, G
    Noris, M
    [J]. HUMAN MOLECULAR GENETICS, 2003, 12 (24) : 3385 - 3395
  • [6] Genetics of HUS:: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome
    Caprioli, Jessica
    Noris, Marina
    Brioschi, Simona
    Pianetti, Gaia
    Castelletti, Federica
    Bettinaglio, Paola
    Mele, Caterina
    Bresin, Elena
    Cassis, Linda
    Gamba, Sara
    Porrati, Francesca
    Bucchioni, Sara
    Monteferrante, Giuseppe
    Fang, Celia J.
    Liszewski, M. K.
    Kavanagh, David
    Atkinson, John P.
    Remuzzi, Giuseppe
    [J]. BLOOD, 2006, 108 (04) : 1267 - 1279
  • [7] COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252
  • [8] de Cordoba SR, 2008, CLIN EXP IMMUNOL, V151, P1, DOI 10.1111/j.1365-2249.2007.03574.x
  • [9] Increased Risk of Cancer Other Than Melanoma in CDKN2A Founder Mutation (p16-Leiden)-Positive Melanoma Families
    de Snoo, Femke A.
    Bishop, D. Timothy
    Bergman, Wilma
    van Leeuwen, Inge
    van der Drift, Clasine
    van Nieuwpoort, Frans A.
    Out-Luiting, Coby J.
    Vasen, Hans F.
    ter Huurne, Jeanet A. C.
    Frants, Rune R.
    Willemze, Rein
    Breuning, Martijn H.
    Gruis, Nelleke A.
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (21) : 7151 - 7157
  • [10] FAMILIAL HEMOLYTIC UREMIC SYNDROME
    EDELSTEN, AD
    TUCK, S
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1978, 53 (03) : 255 - 256